Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Sarcopenia | Research article

Association of gait speed and grip strength with risk of cardiovascular events in patients on haemodialysis: a prospective study

Authors: Atsumi Kuki, Kentaro Tanaka, Akifumi Kushiyama, Yoshihide Tanaka, Shuta Motonishi, Yasuji Sugano, Toru Furuya, Takashi Ozawa

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Gait speed (GS) and handgrip strength (HGS), both factors associated with frailty and sarcopenia, are reportedly associated with CV events in the general population. However, little is known about the impact of these factors on the outcome of patients on dialysis. This study aimed to evaluate whether evaluation of GS and HGS could be associated the onset of fatal/non-fatal cardiovascular (CV) events in patients on haemodialysis (HD).

Methods

One-hundred-eighty-two patients with end-stage renal disease (ESRD) undergoing HD at four dialysis clinics in April 2015 provided written informed consent to participate in the study. We excluded patients who had physical disability, were unable to walk without help, or had recently experienced CV events. Usual GS over a 4-m walk and HGS were measured at baseline, and 173 patients (men, 124; women, 49) were divided into sex-specific quartiles according to GS and HGS and were followed-up for fatal/non-fatal CV events for a median of 2 years. We examined the association of GS and HGS with CV events and determined cut-off values using Cox regression analysis adjusted for age, sex, HD duration, history of CVD, and diabetes.

Results

During the follow-up period, 46 CV events occurred. Both physical performance factors were significantly associated with CV events. Low GS (< 0.82 m/s for men and 0.81 m/s for women) and weak HGS (< 29.0 kg for men and 19.7 kg for women) were associated with CV events. For low vs. high GS, the hazard ratio (HR) for CV events was 2.29 [95% confidence interval (CI): 1.20–4.33; P = 0.01], and for low vs. high HGS, the HR was 2.15 [95% CI: 1.00–5.04; P < 0.05]. These HRs remained significant after adjusting for confounding factors, such as sex, age, dialysis vintage, history of CV disease, and diabetes.

Conclusions

Slow GS and weak HGS in patients on HD were suggested to be independent predictors of fatal/non-fatal CV events.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337–51.CrossRef Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337–51.CrossRef
3.
go back to reference Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–8.CrossRef Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–8.CrossRef
4.
go back to reference Drost D, Kalf A, Vogtlander N, van Munster BC. High prevalence of frailty in end-stage renal disease. Int Urol Nephrol. 2016;48:1357–62.CrossRef Drost D, Kalf A, Vogtlander N, van Munster BC. High prevalence of frailty in end-stage renal disease. Int Urol Nephrol. 2016;48:1357–62.CrossRef
5.
go back to reference Avin KG, Moorthi RN. Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos Rep. 2015;13:173–9.CrossRef Avin KG, Moorthi RN. Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos Rep. 2015;13:173–9.CrossRef
6.
go back to reference Walker SR, Wagner M, Tangri N. Chronic kidney disease, frailty, and unsuccessful aging: a review. J Ren Nutr. 2014;24:364–70.CrossRef Walker SR, Wagner M, Tangri N. Chronic kidney disease, frailty, and unsuccessful aging: a review. J Ren Nutr. 2014;24:364–70.CrossRef
7.
go back to reference Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27:1–15.CrossRef Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27:1–15.CrossRef
8.
go back to reference Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;17:e0169548.CrossRef Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;17:e0169548.CrossRef
9.
go back to reference Onoue Y, Izumiya Y, Hanatani TT, Yamamura S, Kimura Y, et al. A simple sarcopenia screening test predicts future adverse events in patients with heart failure. Int J Cardiol. 2016;215:301–6.CrossRef Onoue Y, Izumiya Y, Hanatani TT, Yamamura S, Kimura Y, et al. A simple sarcopenia screening test predicts future adverse events in patients with heart failure. Int J Cardiol. 2016;215:301–6.CrossRef
10.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRef
11.
go back to reference Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;6:192.PubMedPubMedCentral Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;6:192.PubMedPubMedCentral
12.
go back to reference Sergi G, Veronese N, Fontana L, De Rui M, Bolzetta F, Zambon S, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women the ProVA study. J Am Coll Cardiol. 2015;65:976–83.CrossRef Sergi G, Veronese N, Fontana L, De Rui M, Bolzetta F, Zambon S, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women the ProVA study. J Am Coll Cardiol. 2015;65:976–83.CrossRef
13.
go back to reference Srikanthan P, Horwich TB, Tseng CH. Relation of muscle mass and fat mass to cardiovascular disease mortality. Am J Cardiol. 2016;117:1355–60.CrossRef Srikanthan P, Horwich TB, Tseng CH. Relation of muscle mass and fat mass to cardiovascular disease mortality. Am J Cardiol. 2016;117:1355–60.CrossRef
14.
go back to reference Fonseca Alves DJ, Bartholomeu-Neto J, Júnior ER, Ribeiro Zarricueta BS, Nóbrega OT, Córdova C. Walking speed, risk factors, and cardiovascular events in older adults-systematic review. J Strength Cond Res. 2017;31:3235–44.CrossRef Fonseca Alves DJ, Bartholomeu-Neto J, Júnior ER, Ribeiro Zarricueta BS, Nóbrega OT, Córdova C. Walking speed, risk factors, and cardiovascular events in older adults-systematic review. J Strength Cond Res. 2017;31:3235–44.CrossRef
15.
go back to reference Wu Y, Wang W, Liu T, Zhang D. Association of Grip Strength with Risk of all-cause mortality, cardiovascular diseases, and Cancer in community-dwelling populations:a meta-analysis of prospective cohort studies. J Am Med Dir Assoc. 2017;18:551.e17–35.CrossRef Wu Y, Wang W, Liu T, Zhang D. Association of Grip Strength with Risk of all-cause mortality, cardiovascular diseases, and Cancer in community-dwelling populations:a meta-analysis of prospective cohort studies. J Am Med Dir Assoc. 2017;18:551.e17–35.CrossRef
16.
go back to reference Andersen K, Rasmussen F, Held C, Neovius M, Tynelius P, Sundström J. Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men:cohort study. BMJ. 2015;351:h4543.CrossRef Andersen K, Rasmussen F, Held C, Neovius M, Tynelius P, Sundström J. Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men:cohort study. BMJ. 2015;351:h4543.CrossRef
17.
go back to reference Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRef Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRef
18.
go back to reference Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.PubMed Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.PubMed
19.
go back to reference Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51:314–22.CrossRef Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51:314–22.CrossRef
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef
21.
go back to reference Bonsdorff MBV, Groffen DA, Vidal JS, et al. Rantanen T, Jonsson PV, Garcia M et al. coronary artery calcium and physical performance as determinants of mortality in older age: the AGESReykjavik study. Int J Cardiol. 2013;168:2094–9.CrossRef Bonsdorff MBV, Groffen DA, Vidal JS, et al. Rantanen T, Jonsson PV, Garcia M et al. coronary artery calcium and physical performance as determinants of mortality in older age: the AGESReykjavik study. Int J Cardiol. 2013;168:2094–9.CrossRef
22.
go back to reference Elbaz A, Sabia S, Brunner E, Shipley M, Marmot M, Kivimaki M, et al. Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study. Age (Dordr). 2013;35:943–52.CrossRef Elbaz A, Sabia S, Brunner E, Shipley M, Marmot M, Kivimaki M, et al. Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study. Age (Dordr). 2013;35:943–52.CrossRef
23.
go back to reference Kuo HK, Yu YH. The relation of peripheral arterial disease to leg force, gait speed, and functional dependence among older adults. J Gerontol A Biol Sci Med Sci. 2008;63:384–90.CrossRef Kuo HK, Yu YH. The relation of peripheral arterial disease to leg force, gait speed, and functional dependence among older adults. J Gerontol A Biol Sci Med Sci. 2008;63:384–90.CrossRef
24.
go back to reference McDermott MM, Guralnik JM, Ferrucci L, Criqui MH, Greenland P, Tian L, et al. Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race. Vasc Surg. 2005;42:1131–7.CrossRef McDermott MM, Guralnik JM, Ferrucci L, Criqui MH, Greenland P, Tian L, et al. Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race. Vasc Surg. 2005;42:1131–7.CrossRef
25.
go back to reference McDermott MM, Carroll TJ, Kibbe M, Kramer CM, Liu K, Guralnik JM, et al. Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging. 2013;6:687–94.CrossRef McDermott MM, Carroll TJ, Kibbe M, Kramer CM, Liu K, Guralnik JM, et al. Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging. 2013;6:687–94.CrossRef
26.
go back to reference Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108:191–5.CrossRef Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108:191–5.CrossRef
27.
go back to reference Welmer AK, Angleman S, Rydwik E, Fratiglioni L, Qiu C. Association of cardiovascular burden with mobility limitation among elderly people: a population based study. PLoS One. 2013;8:1–7.CrossRef Welmer AK, Angleman S, Rydwik E, Fratiglioni L, Qiu C. Association of cardiovascular burden with mobility limitation among elderly people: a population based study. PLoS One. 2013;8:1–7.CrossRef
28.
go back to reference Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A Biol Sci Med Sci. 2013;68:39–46.CrossRef Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A Biol Sci Med Sci. 2013;68:39–46.CrossRef
29.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.CrossRef
30.
go back to reference Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet. 2015;386:266–73.CrossRef Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet. 2015;386:266–73.CrossRef
31.
go back to reference Strand BH, Cooper R, Bergland A, Jørgensen L, Schirmer H, Skirbekk V, et al. The association of grip strength from midlife onwards with all-cause and cause-specific mortality over 17 years of follow-up in the Tromsø study. J Epidemiol Community Health. 2016;70:1214–21.CrossRef Strand BH, Cooper R, Bergland A, Jørgensen L, Schirmer H, Skirbekk V, et al. The association of grip strength from midlife onwards with all-cause and cause-specific mortality over 17 years of follow-up in the Tromsø study. J Epidemiol Community Health. 2016;70:1214–21.CrossRef
32.
go back to reference Nofuji Y, Shinkai S, Taniguchi Y, Amano H, Nishi M, Murayama H, et al. Associations of walking speed, grip strength, and standing balance with Total and cause-specific mortality in a general population of Japanese elders. J Am Med Dir Assoc. 2016;17:184.e1–7.CrossRef Nofuji Y, Shinkai S, Taniguchi Y, Amano H, Nishi M, Murayama H, et al. Associations of walking speed, grip strength, and standing balance with Total and cause-specific mortality in a general population of Japanese elders. J Am Med Dir Assoc. 2016;17:184.e1–7.CrossRef
33.
go back to reference Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yosida D, et al. Midlife and late life handgrip strength and risk of cause-specific death in a general Japanese population: the Hisayama study. J Epidemiol Community Health. 2014;68:663–8.CrossRef Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yosida D, et al. Midlife and late life handgrip strength and risk of cause-specific death in a general Japanese population: the Hisayama study. J Epidemiol Community Health. 2014;68:663–8.CrossRef
34.
go back to reference Kim JK, Kim SG, Oh JE, Lee YK, Noh JW, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34:599–607.CrossRef Kim JK, Kim SG, Oh JE, Lee YK, Noh JW, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34:599–607.CrossRef
35.
go back to reference Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40:423–9.CrossRef Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40:423–9.CrossRef
36.
go back to reference Kong YK. The effects of co-ordinating postures with shoulder and elbow flexion angles on maximum grip strength and upper-limb muscle activity in standing and sitting postures. Int J Occup Saf Ergon. 2014;20:595–606.CrossRef Kong YK. The effects of co-ordinating postures with shoulder and elbow flexion angles on maximum grip strength and upper-limb muscle activity in standing and sitting postures. Int J Occup Saf Ergon. 2014;20:595–606.CrossRef
37.
go back to reference Liao WC, Wang CH, Yu SY, Chen LY, Wang CY. Grip strength measurement in older adults in Taiwan: a comparison of three testing positions. Australas J Ageing. 2014;33:278–82.CrossRef Liao WC, Wang CH, Yu SY, Chen LY, Wang CY. Grip strength measurement in older adults in Taiwan: a comparison of three testing positions. Australas J Ageing. 2014;33:278–82.CrossRef
38.
go back to reference Rehfuss JP, Berceli SA, Y BSMH, Kubilis PS, Beck AW, Huber TS, et al. The spectrum of hand dysfunction after hemodialysis fistula placement. Kidney Int Rep. 2017;2:332–41.CrossRef Rehfuss JP, Berceli SA, Y BSMH, Kubilis PS, Beck AW, Huber TS, et al. The spectrum of hand dysfunction after hemodialysis fistula placement. Kidney Int Rep. 2017;2:332–41.CrossRef
39.
go back to reference Kmentova T, Valerianova A, Kovarova L, Lachmanova J, Hladinova Z, Malik J. Decrease of muscle strength in vascular access hand due to silent ischaemia. J Vasc Access. 2018;1:1129729818763287. Kmentova T, Valerianova A, Kovarova L, Lachmanova J, Hladinova Z, Malik J. Decrease of muscle strength in vascular access hand due to silent ischaemia. J Vasc Access. 2018;1:1129729818763287.
40.
go back to reference Saevereid HA, Schnohr P, Prescott E. Speed and duration of walking and other leisure time physical activity and the risk of heart failure: a prospective cohort study from the Copenhagen City heart study. PLoS One. 2014;9:e89909.CrossRef Saevereid HA, Schnohr P, Prescott E. Speed and duration of walking and other leisure time physical activity and the risk of heart failure: a prospective cohort study from the Copenhagen City heart study. PLoS One. 2014;9:e89909.CrossRef
41.
go back to reference Stamatakis E, Kelly P, Strain T, Murtagh EM, Ding D, Murphy M. Self-rated walking pace and all-cause, cardiovascular disease and cancer mortality: individual participant pooled analysis of 50225 walkers from 11 population British cohorts. Br J Sports Med. 2018;52:761–8.CrossRef Stamatakis E, Kelly P, Strain T, Murtagh EM, Ding D, Murphy M. Self-rated walking pace and all-cause, cardiovascular disease and cancer mortality: individual participant pooled analysis of 50225 walkers from 11 population British cohorts. Br J Sports Med. 2018;52:761–8.CrossRef
42.
go back to reference Artero EG, Lee DC, Lavie CJ, España-Romero V, Sui X, Church TS, et al. Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev. 2012;32:351358.CrossRef Artero EG, Lee DC, Lavie CJ, España-Romero V, Sui X, Church TS, et al. Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev. 2012;32:351358.CrossRef
43.
go back to reference Fritz NE, McCarthy CJ, Adamo DE. Handgrip strength as a means of monitoring progression of cognitive decline - a scoping review. Ageing Res Rev. 2017;35:112–23.CrossRef Fritz NE, McCarthy CJ, Adamo DE. Handgrip strength as a means of monitoring progression of cognitive decline - a scoping review. Ageing Res Rev. 2017;35:112–23.CrossRef
44.
go back to reference Lee SY, Yang DH, Hwang E, Kang SH, Park SH, Kim TW, et al. The prevalence, association, and clinical outcomes of frailty in maintenance Dialysis patients. J Ren Nutr. 2017;27:106–12.CrossRef Lee SY, Yang DH, Hwang E, Kang SH, Park SH, Kim TW, et al. The prevalence, association, and clinical outcomes of frailty in maintenance Dialysis patients. J Ren Nutr. 2017;27:106–12.CrossRef
Metadata
Title
Association of gait speed and grip strength with risk of cardiovascular events in patients on haemodialysis: a prospective study
Authors
Atsumi Kuki
Kentaro Tanaka
Akifumi Kushiyama
Yoshihide Tanaka
Shuta Motonishi
Yasuji Sugano
Toru Furuya
Takashi Ozawa
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Sarcopenia
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1370-6

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue